Quick Answer
FENNEC PHARMACEUTICALS INC. reported Cash and Equivalents of $36.79 million for fiscal year 2025.
FENNEC PHARMACEUTICALS INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $36.79M | +38.1% |
| 2024 | $26.63M | +100.7% |
| 2023 | $13.27M | -44.2% |
| 2022 | $23.77M | +12.7% |
| 2021 | $21.10M | -30.5% |
| 2020 | $30.34M | +122.3% |
| 2019 | $13.65M | -40.1% |
| 2018 | $22.78M | -19.4% |
| 2017 | $28.26M | +619.8% |
| 2016 | $3.93M | +316.8% |
| 2015 | $942.0K | -59.2% |
| 2014 | $2.31M | +38.7% |
| 2013 | $1.66M | -27.8% |
| 2012 | $2.30M | -56.5% |
| 2011 | $5.30M | -10.9% |
| 2010 | $5.95M | +768.2% |
| 2009 | $685.0K | — |
| 1996 | $0.00 | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $21.95M | -45.6% | +17.3% |
| June 30, 2025 | $18.70M | -56.6% | -17.5% |
| March 31, 2025 | $22.68M | -55.7% | -14.9% |
| December 31, 2024 | $26.63M | +100.7% | -33.9% |
| September 30, 2024 | $40.32M | +225.2% | -6.4% |
| June 30, 2024 | $43.05M | +187.8% | -15.9% |
| March 31, 2024 | $51.18M | +178.3% | +285.7% |
| December 31, 2023 | $13.27M | -44.2% | +7.0% |
- FENNEC PHARMACEUTICALS INC. showed an increase of +38.1% in Cash and Equivalents compared to the prior fiscal year.
- The most recent figure is from FENNEC PHARMACEUTICALS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: